Synthesis and inhibitory action on HMG-CoA synthase of racemic and optically active oxetan-2-ones (β-Lactones)

This publication has 54 references indexed in Scilit:

• Efficacy of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in the treatment of patients with hypercholesterolemia: a meta-analysis of clinical trials
  Clinical Therapeutics, 1997
• Pharmacodynamics and Pharmacokinetics of the HMG-CoA Reductase Inhibitors
  Clinical Pharmacokinetics, 1997
• The biosynthesis of C5–C25 terpenoid compounds
  Natural Product Reports, 1997
• Planned, ongoing and recently completed clinical trials for atherosclerosis prevention and regression: an update
  Expert Opinion on Investigational Drugs, 1997
• The biology of HMG-CoA reductase: the pros of contra-regulation
  Trends in Biochemical Sciences, 1996
• Novel synthetic strategy for HMG-CoA reductase inhibitors
  Published by Walter de Gruyter GmbH ,1996
• Amplification and direct sequencing of a cDNA encoding human cytosolic 3-hydroxy-3-methylglutaryl-coenzyme A synthase
  Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1992
• The Biosynthesis of Secondary Metabolites
  Published by Springer Nature ,1981
• Some properties of 3-hydroxy-3-methylglutaryl-coenzyme A synthase from ox liver
  Biochemical Journal, 1978
• The kinetic mechanism of 3-hydroxy-3-methylglutaryl-coenzyme A synthase from baker's yeast
  Biochemical Journal, 1972